# Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients

> **NCT02944214** · NA · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Hyperuricemia
- Abnormal Renal Function

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Benzbromarone

## Key facts

- **NCT ID:** NCT02944214
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944214, "Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02944214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*